{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:50:04Z","timestamp":1760385004598,"version":"3.37.0"},"reference-count":35,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1254\/jphs.09142fp","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T10:41:22Z","timestamp":1253270482000},"page":"44-52","source":"Crossref","is-referenced-by-count":19,"title":["Effects of Some Antipsychotics and a Benzodiazepine Hypnotic on the Sleep-Wake Pattern in an Animal Model of Schizophrenia"],"prefix":"10.1254","volume":"111","author":[{"given":"Takayuki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Hiatt JF, Floyd TC, Katz PH, Feinberg I. Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry. 1985;42:797&ndash;802.","DOI":"10.1001\/archpsyc.1985.01790310059007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Keshavan MS, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in schizophrenia: a critical review. Compr Psychiatry. 1990;31:34&ndash;47.","DOI":"10.1016\/0010-440X(90)90052-T"},{"key":"3","unstructured":"3 Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Rosas M, Brunner E. Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin. 2004;56:345&ndash;350."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Levin ED, Caldwell DP, Perraut C. Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol Biochem Behav. 2007;86:597&ndash;605.","DOI":"10.1016\/j.pbb.2007.02.005"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.06.035"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus. 2008;18:125&ndash;134.","DOI":"10.1002\/hipo.20367"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Pinault D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry. 2008;63:730&ndash;735.","DOI":"10.1016\/j.biopsych.2007.10.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kirino E. Correlation between P300 and EEG rhythm in schizophrenia. Clin EEG Neurosci. 2004;35:137&ndash;146.","DOI":"10.1177\/155005940403500306"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kajimura N, Kato M, Okuma T, Sekimoto M, Watanabe T, Takahashi K. A quantitative sleep-EEG study on the effects of benzodiazepine and zopiclone in schizophrenic patients. Schizophr Res. 1995;15:303&ndash;312.","DOI":"10.1016\/0920-9964(94)00054-C"},{"key":"10","unstructured":"10 Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 6th ed. San Diego: Academic Press; 2007."},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.08059FP"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.32.51"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.08.024"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.08229FP"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hanania T, Negri CA, Dunwiddie TV, Zahniser NR. N-methyl-D-aspartate receptor responses are differentially modulated by noncompetitive receptor antagonists and ethanol in inbred long-sleep and short-sleep mice: behavior and electrophysiology. Alchol Clin Exp Res. 2000;24:1750&ndash;1758.","DOI":"10.1111\/j.1530-0277.2000.tb01977.x"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02558.x"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2006.08.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Andersen ML, Antunes IB, Silva A, Alvarenga TA, Baracat EC, Tufik S. Effects of sleep loss on sleep architecture in Wistar rats: gender-specific rebound sleep. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:975&ndash;983.","DOI":"10.1016\/j.pnpbp.2008.01.007"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Machado RB, Hip&oacute;lide DC, Benedito-Silva AA, Tufik S. Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res. 2004;1004:45&ndash;51.","DOI":"10.1016\/j.brainres.2004.01.019"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Maehara S, Hikichi H, Satow A, Okuda S, Ohta H. Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia. Pharmacol Biochem Behav. 2008;91:140&ndash;149.","DOI":"10.1016\/j.pbb.2008.06.023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Duncan GE, Moy SS, Lieberman JA, Koller BH. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav. 2006;85:481&ndash;491.","DOI":"10.1016\/j.pbb.2006.09.017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Duncan GE, Moy SS, Lieberman JA, Koller BH. Effects of haloperidol, clozapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl). 2006;184:190&ndash;200.","DOI":"10.1007\/s00213-005-0214-1"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0071924"},{"issue":"2","key":"24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0022-3565(25)38367-9","volume":"266","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ma J, Ye N, Cohen BM. Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:647&ndash;657.","DOI":"10.1016\/j.pnpbp.2005.11.040"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00315-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry. 2000;47:468&ndash;470.","DOI":"10.1016\/S0006-3223(99)00273-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Lindberg N, Virkkunen M, Tani P, Appelberg B, Virkkala J, Rimon R, et al. Effect of a single-dose of olanzapine on sleep in healthy females and males. Int Clin Psychopharmacol. 2002;17:177&ndash;184.","DOI":"10.1097\/00004850-200207000-00004"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.01.038"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00911-5"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0061173"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Bastin CH, LeBlanc M, Carrier J, Morin CM. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep. 2003;26:313&ndash;317.","DOI":"10.1093\/sleep\/26.3.313"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Van Lier H, Drinkenburg WH, van Eeten YJ, Coenen AM. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology. 2004;47:163&ndash;174.","DOI":"10.1016\/j.neuropharm.2004.03.017"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)02698-7"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(94)90077-9"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:24:25Z","timestamp":1739345065000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/111\/1\/111_09142FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.09142fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"type":"print","value":"1347-8613"},{"type":"electronic","value":"1347-8648"}],"subject":[],"published":{"date-parts":[[2009]]}}}